Antiviral Therapies in the Management of Chronic Hepatitis C: The Present and the Future

Antiviral Therapies in the Management of Chronic Hepatitis C: The Present and the Future

 

Accreditation | Agenda | Faculty | Registration

 

Agenda

6:00pm
Registration and Dinner

6:30pm
Welcome and Introduction

6:40 pm
Treating Hepatitis C:  What is your Current Practice?
This open and interactive session will allow the speaker to facilitate a discussion with the participants about their current practice for screening for and treating HCV infection. The speaker will ask
participants to:

  • Discuss their practice and the barriers they encounter to treating HCV infection
  • Reflect on a recent interaction with a patient with HCV
  • Discuss how they managed the patient and if they believe the management was successful

7:00pm
Screening, Treating, and Monitoring HCV-infected Patients
Using a case-based format, the following topics will be discussed:

  • Identification of patients suitable for treatment with DAA therapy
  • Difficult treatment decisions: patients with cirrhosis, patients with previous partial response or non-response to therapy, treatment of patients with comorbid conditions
  • Treatment algorithms for the use of DAAs in the treatment of HCV
  • Recognition and management of side effects of DAA therapy
  • Overview of the data regarding treatment efficacy for DAA therapy in HCV

8:40pm
Evaluation

8:45pm
Adjourn